Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Beauty Health Co (SKIN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/26/2025: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $1.93
1 Year Target Price $1.93
| 0 | Strong Buy |
| 0 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -52.8% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/26/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 186.15M USD | Price to earnings Ratio - | 1Y Target Price 1.93 |
Price to earnings Ratio - | 1Y Target Price 1.93 | ||
Volume (30-day avg) 9 | Beta 1.18 | 52 Weeks Range 0.78 - 2.69 | Updated Date 12/28/2025 |
52 Weeks Range 0.78 - 2.69 | Updated Date 12/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.16 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.89% | Operating Margin (TTM) -8.83% |
Management Effectiveness
Return on Assets (TTM) -2.92% | Return on Equity (TTM) -18.73% |
Valuation
Trailing PE - | Forward PE 106.38 | Enterprise Value 345737466 | Price to Sales(TTM) 0.62 |
Enterprise Value 345737466 | Price to Sales(TTM) 0.62 | ||
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA 11.87 | Shares Outstanding 127503059 | Shares Floating 82113245 |
Shares Outstanding 127503059 | Shares Floating 82113245 | ||
Percent Insiders 11.66 | Percent Institutions 88.99 |
Upturn AI SWOT
Beauty Health Co
Company Overview
History and Background
Beauty Health Co. (NASDAQ: BHAT) was founded in 2019 and is a global beauty health company. It is the parent company of Hydrafacial, a well-known brand in the professional skincare and aesthetic treatments market. The company's evolution has been marked by its focus on expanding the reach and accessibility of its signature hydradermabrasion technology and building a strong community of aesthetic professionals.
Core Business Areas
- Beauty Health System (Hydrafacial): This is the primary business segment, encompassing the Hydrafacial device, its proprietary treatment protocols, and a range of skincare consumables (e.g., serums, masks) used in conjunction with the device. These treatments are delivered through a network of professional aesthetic providers.
- Growth & Expansion: Focuses on expanding its global footprint, developing new technologies and product offerings, and strategic partnerships to enhance its service portfolio and market penetration.
Leadership and Structure
Beauty Health Co. is led by a management team with experience in the beauty, wellness, and technology sectors. The organizational structure is designed to support its global operations, R&D, sales, and marketing efforts, with a strong emphasis on its professional partner network.
Top Products and Market Share
Key Offerings
- Hydrafacial Device and Treatments: The core offering is the Hydrafacial system, a non-invasive skin resurfacing procedure that cleanses, exfoliates, extracts, and hydrates the skin. Market share data for specific devices is not publicly granular, but Hydrafacial is a leading brand in the professional hydradermabrasion market, competing with brands like HydraFacial MD (owned by The Beauty Health Company), DermaSweep, and other professional-grade facial treatment systems. Its revenue is primarily driven by device sales and recurring revenue from consumables and service contracts.
- Hydrafacial Consumables and Serums: A range of proprietary serums and boosters designed to address various skin concerns (e.g., hydration, plumping, brightening) that are used during Hydrafacial treatments. These consumables are sold to licensed professionals and contribute significantly to recurring revenue. Competitors include other professional skincare brands that offer specialized treatment serums.
Market Dynamics
Industry Overview
Beauty Health Co. operates within the rapidly growing global aesthetic and professional skincare market. This industry is driven by increasing consumer demand for non-invasive beauty treatments, technological advancements, and a growing awareness of skincare. Key trends include personalization, preventative aging, and the integration of technology in beauty services.
Positioning
Beauty Health Co. is positioned as a leader in the professional hydradermabrasion segment, renowned for its signature Hydrafacial experience. Its competitive advantages lie in its strong brand recognition, patented technology, extensive global network of aesthetic providers, and a recurring revenue model driven by consumables. The company focuses on providing a premium, customizable treatment that appeals to both consumers and medical/aesthetic professionals.
Total Addressable Market (TAM)
The global aesthetic and professional skincare market is substantial and continues to grow. While specific TAM figures for hydradermabrasion are not precisely defined publicly, the broader aesthetic device market is estimated to be in the tens of billions of dollars globally, with significant growth projected. Beauty Health Co. targets a significant portion of this TAM through its professional partner network, which serves a large and expanding consumer base seeking advanced skincare treatments.
Upturn SWOT Analysis
Strengths
- Strong brand recognition and loyalty for the Hydrafacial brand.
- Proprietary technology and treatment protocols.
- Extensive global network of over 20,000 aesthetic providers.
- Recurring revenue model through consumables and service agreements.
- Focus on professional-grade, non-invasive treatments addressing multiple skin concerns.
Weaknesses
- Reliance on a network of third-party providers for service delivery.
- Potential for increased competition from new entrants and existing players developing similar technologies.
- Susceptibility to economic downturns affecting discretionary spending on aesthetic treatments.
- Geographic concentration of revenue in certain markets.
Opportunities
- Expansion into emerging markets with growing demand for aesthetic services.
- Development of new technologies, devices, and enhanced treatment protocols.
- Strategic partnerships and acquisitions to broaden service offerings and market reach.
- Increased consumer demand for personalized and data-driven skincare solutions.
- Leveraging digital platforms for consumer engagement and provider support.
Threats
- Intensifying competition from other aesthetic device manufacturers and skincare brands.
- Changes in consumer preferences and trends in the beauty industry.
- Regulatory changes affecting the aesthetic and medical device industries.
- Economic slowdowns impacting consumer spending on non-essential services.
- Potential for negative publicity or adverse events associated with treatments.
Competitors and Market Share
Key Competitors
- Lumenis Ltd. (Private)
- Cutera Inc. (CUTR)
- Cynosure, LLC (Private)
- Syneron Medical (part of Candela Medical - Private)
Competitive Landscape
Beauty Health Co. holds a strong position in the hydradermabrasion segment due to its brand recognition and established network. However, it faces competition from companies offering a broader range of aesthetic devices and treatments, as well as emerging technologies. Its advantage lies in the simplicity, effectiveness, and customizable nature of the Hydrafacial, offering a recurring revenue stream. Disadvantages can arise from a more focused product offering compared to diversified competitors and reliance on the professional channel.
Major Acquisitions
HydraFacial
- Year: 2019
- Acquisition Price (USD millions):
- Strategic Rationale: While not a direct acquisition in the traditional sense, the formation of Beauty Health Co. as the parent entity for Hydrafacial consolidated its operations and facilitated its growth as a public company, enabling greater capital access and strategic expansion.
Growth Trajectory and Initiatives
Historical Growth: Beauty Health Co. has experienced significant growth since its inception, largely through the expansion of its Hydrafacial brand into new geographic markets and the increasing adoption by aesthetic professionals. This growth has been fueled by strong consumer demand for its signature treatments.
Future Projections: Analyst projections for Beauty Health Co. typically focus on continued revenue growth driven by global expansion, new product introductions, and deeper penetration within existing markets. Future growth is expected to be supported by the ongoing demand for non-invasive aesthetic procedures and the company's strategic initiatives.
Recent Initiatives: Recent initiatives often include the launch of new Hydrafacial devices and treatment protocols, expansion of its partnership programs, international market penetration efforts, and potential acquisitions to enhance its technology or service portfolio.
Summary
Beauty Health Co. is a prominent player in the global aesthetic device market, driven by its popular Hydrafacial brand. The company benefits from strong brand recognition, a loyal professional network, and a recurring revenue model, positioning it well within the growing demand for non-invasive skincare. However, it must navigate increasing competition, economic sensitivities, and the need for continuous innovation to maintain its leadership and capitalize on future market opportunities.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (e.g., SEC filings)
- Financial News and Data Providers (e.g., Bloomberg, Refinitiv)
- Market Research Reports (e.g., Grand View Research, Mordor Intelligence)
- Industry Publications
Disclaimers:
This JSON output is generated for informational purposes only and should not be considered as financial advice. The data presented is based on publicly available information and may not be exhaustive or completely up-to-date. Market share data and competitor information are estimates and subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | CEO & President Mr. Pedro Malha | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 769 | Website https://www.beautyhealth.com |
Full time employees 769 | Website https://www.beautyhealth.com | ||
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.